Cell Therapy for Immunomodulation in Kidney Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Tocilizumab
Related studies linked through entity extraction aliases.
A Phase Ib Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Cibisatamab in Combination With Atezolizumab After Pretreatment With Obinutuzumab in Participants With Previously Treated Metastatic Colorectal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- Status
- RECRUITING
- Phase
- PHASE2
Mild-Intensity Whole Body Hyperthermia (WBH) for Major Depressive Disorder
- Status
- SUSPENDED
- Phase
- PHASE2
Therapeutic Drug Monitoring of Tocilizumab in Rheumatoid Arthritis
- Status
- UNKNOWN
- Phase
- PHASE4
Giant Cell Arteritis Treatment With Ultra-short Glucocorticoids and Tocilizumab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)
- Status
- COMPLETED
- Phase
- PHASE4
Tocilizumab Plus a Short Prednisone Taper for GCA
- Status
- COMPLETED
- Phase
- PHASE4
Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck
- Status
- RECRUITING
- Phase
- PHASE2
PROACTIVE: Preventing Acute/Chronic GVHD With TocIlizumab Combined With GVHD Prophylaxis Post allogEneic Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Monotherapy or in Combination With Polatuzumab Vedotin in Elderly/Unfit Participants With Previously Untreated Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase Ib/II Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Tocilizumab in Cardiac Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant
- Status
- TERMINATED
- Phase
- PHASE1
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of RO7172508 in Patients With Locally Advanced and/or Metastatic CEA-Positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Tocilizumab for Cytokine Release Syndrome Prophylaxis in Haploidentical Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I, Pharmacokinetic, Safety and Tolerability Study in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1